Abstract P5-16-15: Lymph-vascular invasion in the absence of stomal invasion after neoadjuvant therapy: A rare pattern of residual carcinoma that lacks an AJCC/UICC T category
Abstract:Background: Response to neoadjuvant chemotherapy in breast cancer serves as an important prognostic indicator, as patients whose estrogen receptor (ER) negative and/or HER2 positive cancers undergo a pathologic complete response (pCR) have an excellent outcome. Guidelines on classification of treatment response are available, but data is lacking for the rare event where lymph-vascular invasion (LVI) is the only residual disease in the breast. Only one study (Rabban JT et al, Am J Surg Pathol, 2009) has investi… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.